The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 758-760

  Wu, Tony T ^a,b   Chen, Jian Hsu ^a   Lee, Ying Huei ^a   Huang, Jong Khing ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Bladder neoplasms; Genes, bcl 2; Genes, p53; Ki 67 antigen; Prognosis

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER RECURRENCE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

EID: 0033973839     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67798-1     Document Type: Article

References (16)

1. Vollmer, R. T., Humphrey, P. A., Swanson, P. E. et al: Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2. Cancer, 82: 715, 1998
2. Tsujihashi, H., Nakanishi, A., Matsuda, H. et al: Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining. J Urol, 145: 846, 1991
3. Nakopoulou, L., Vourlakou, C., Zervas, A. et al: The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol, 29: 146, 1998
4. Vorreuther, R., Hake, R., Borchmann, P. et al: Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors. Urol Int, 59: 88, 1997
5. Li, B., Kanamaru, H., Noriki, S. et al: Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder. Urol Res, 26: 235, 1998
6. Hockenbery, D., Nunez, G., Milliman, C. et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348: 334, 1990
7. Lipponen, P. K., Aaltomaa, S. and Eskelinen, M.: Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours. Histopathology, 28: 135, 1996
8. Atug, F., Turkeri, L., Ozyurek, M. et al: Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder. Int Urol Nephrol, 30: 455, 1998
9. Bush, C., Price, P., Norton, J. et al: Proliferation in human bladder carcinoma measured by Ki-67 antibody labeling: its potential clinical importance. Br J Cancer, 64: 357, 1991
10. Mulder, A. H., Van Hootegem, J. C., Sylvester, R. et al: Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol, 166: 37, 1992
11. Fontana, D., Bellina, M., Gubetta, L. et al: Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. J Urol, 148: 1149, 1992
12. Shi, S. R., Key, M. E. and Kalra, K. L.: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem, 39: 741, 1991
13. Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer, 53: 365, 1993
14. Popov, Z., Hoznek, A., Colombel, M. et al: The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer, 80: 1472, 1997
15. Kirsh, E. J., Baunoch, D. A. and Stadler, W. M.: Expression of bcl-2 and bcl-x in bladder cancer. J Urol, 159: 1348, 1998
16. Liukkonen, T. J., Lipponen, P. K., Helle, M. et al: Immunoreactivity of bcl-2, p53, and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer. Finn- bladder III Group. Urol Res, 25: 1, 1997